Medication utilization for patients with chronic rhinosinusitis with nasal polyposis and asthma in 12 months pre- and post-dupilumab initiation.
asthma
chronic rhinosinusitis
quality of life
steroid therapy
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
26 Feb 2024
26 Feb 2024
Historique:
revised:
31
01
2024
received:
28
08
2023
accepted:
14
02
2024
medline:
27
2
2024
pubmed:
27
2
2024
entrez:
27
2
2024
Statut:
aheadofprint
Résumé
This study examines the impact of dupilumab on medication use for chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma patients. Patients on dupilumab had a reduction in oral/inhaled/topical steroids, antibiotics, and leukotriene receptor antagonists (LTRAs). The reduction in medication use had no impact on total polyp or SNOT-22 scores.
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.
Références
Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016;9:45. doi:10.2147/JAA.S86251
Heffler E, Nascimento Girardi Madeira L, Ferrando M, et al. Clinical commentary review inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6:776-781. doi:10.1016/j.jaip.2018.01.025
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(S29):1-464. doi:10.4193/RHIN20.600
Geng B, Bachert C, Busse WW, et al. Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies. J Allergy Clin Immunol Pract. 2022;10:732-741. doi: 10.1016/j.jaip.2021.12.006
Chauhan BF, Jeyaraman MM, Mann AS, et al. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma (Review). Cochrane Database Syst Rev. 2017;3:CD010347 doi:10.1002/14651858.CD010347.pub2
Buchheit KM, Sohail A, Hacker J, et al. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2022;150(2):415. doi: 10.1016/J.JACI.2022.04.007